TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Q2 2025 Earnings Call Transcript August 12, 2025
TriSalus Life Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were $-0.22.
Operator: Good afternoon, and welcome to TriSalus Life Sciences Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes. I will now turn the call over to Jeremy Feffer, Managing Director with LifeSci Advisors....
